ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,000 | 0.0% | 130 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | 0.0% | 130 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | -16.7% | 130 | -15.6% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | +20.0% | 154 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | -28.6% | 154 | -62.6% | 0.00% | -33.3% |
| Q4 2017 | $7,000 | 0.0% | 412 | +1.2% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | +16.7% | 407 | -2.6% | 0.00% | 0.0% |
| Q2 2017 | $6,000 | -33.3% | 418 | -0.2% | 0.00% | -40.0% |
| Q1 2017 | $9,000 | +50.0% | 419 | -4.6% | 0.01% | +66.7% |
| Q4 2016 | $6,000 | +50.0% | 439 | +91.7% | 0.00% | 0.0% |
| Q3 2016 | $4,000 | -33.3% | 229 | -7.7% | 0.00% | -25.0% |
| Q2 2016 | $6,000 | +20.0% | 248 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -28.6% | 248 | +6.0% | 0.00% | -20.0% |
| Q4 2015 | $7,000 | +75.0% | 234 | +91.8% | 0.01% | +66.7% |
| Q3 2015 | $4,000 | – | 122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
| Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
| Baupost Group | 9,773,616 | $15,736 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
| MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
| 683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
| WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
| STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
| XTX Topco Ltd | 136,841 | $220,314 | 0.04% |